Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2019 08:45 ET | Source: Precipio, Inc.

Precipio CEO Issues Shareholder Update Letter

NEW HAVEN, Conn., March 11, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), issues the following letter from CEO Ilan Danieli. Dear Shareholders, ...
March 05, 2019 07:40 ET | Source: Precipio, Inc.

Continued ICP Orders From Japanese Customers

NEW HAVEN, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it continues to receive both new and repeat business from...
February 18, 2019 17:00 ET | Source: Precipio, Inc.

Precipio Provides Corporate Update Shareholder Call

NEW HAVEN, Conn., Feb. 18, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), will host a conference call on Thursday, February 21st, 2019 at 4:30pm to review...
February 14, 2019 08:18 ET | Source: Precipio, Inc.

Precipio 2018 Revenues Increase 66% over 2017; Company Takes Substantial Cost-Cutting Measures Towards Profitability

NEW HAVEN, Conn., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today its preliminary unaudited 2018 Revenues of $2.8M, representing 66%...
January 29, 2019 07:47 ET | Source: Precipio, Inc.

Precipio Gains Recognition on NY Radio Station WHPC Show “My Hometown” As Innovator Battling Cancer Misdiagnosis

NEW HAVEN, Conn., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced a recent radio show interview of Ilan Danieli, Precipio’s CEO, on...
January 15, 2019 07:47 ET | Source: Precipio, Inc.

Makati Medical Center in the Philippines Adopts Precipio’s ICE COLD-PCR Mutation Enrichment Technology for Liquid Biopsies

NEW HAVEN, Conn., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced that Makati Medical Center (MakatiMed) in Manila, the Philippines,...
January 10, 2019 07:45 ET | Source: Precipio, Inc.

Precipio Announces First US Government Customer for ICE COLD-PCR™ Mutation Enrichment Technology

NEW HAVEN, Conn., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has been approved by the United States Department of...
January 08, 2019 07:45 ET | Source: Precipio, Inc.

Precipio Files Patent for HemeScreen™, its Novel Molecular Assay

NEW HAVEN, Conn., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced the filing of a patent for its proprietary HemeScreen panel....
December 12, 2018 08:15 ET | Source: Precipio, Inc.

Precipio Reports Strong Mid-Quarter Growth

NEW HAVEN, Conn., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that based on metrics observed in its October and November revenue...
December 04, 2018 09:15 ET | Source: Precipio, Inc.

Precipio Announces $1.2 Million Securities Purchase Agreement With Participation from Members of Its Board of Directors, and other Investors

NEW HAVEN, Conn., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has entered into a $1.2 million Securities Purchase Agreement...